PAREXEL INTERNATIONAL CORPORATION

Inactive Instrument

PAREXEL International Corporation Stock

Equities

US6994621075

Biotechnology & Medical Research

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Chart PAREXEL International Corporation

Duration

Period

Style

Latest news about PAREXEL International Corporation

PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion	17-06-20	RE
PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion	17-06-20	RE
PAREXEL International : Contract research firm Parexel International explores sale - sources	17-05-08	RE

Press releases PAREXEL International Corporation

Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships	19-06-23	BU
PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry	17-12-12	BU
PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry	17-11-15	BU
PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International	17-09-29	BU
PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management	17-09-18	BU

More press releases

News in other languages on PAREXEL International Corporation

PAREXEL : ERWEITERT SEINE CLINICAL TRIAL SUPPLY UND LOGISTIK-SERVICES MIT DER ERÖFFUNG SEINES NEUEN EUROPÄISCHEN DISTRIBUTIONS- UND DIENSTLEISTUNGSZENTRUMS

14-11-12

Managers and Directors - PAREXEL International Corporation

Managers	Title	Age	Since
Duncan MacDonald CEO	Chief Executive Officer	56	-
Gregory Rush DFI	Director of Finance/CFO	56	-
Amy McKee CTO	Chief Tech/Sci/R&D Officer	52	18-12-31

Members of the board	Title	Age	Since
Sherilyn McCoy CHM	Chairman	65	-
Duncan MacDonald CEO	Chief Executive Officer	56	-
May Kin Ho BRD	Director/Board Member	71	15-08-25

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+25.69%	47.9B
LONZA GROUP AG	+47.58%	41.42B
IQVIA HOLDINGS INC.	-3.46%	40.7B
CELLTRION, INC.	-6.20%	28.92B
ICON PUBLIC LIMITED COMPANY	+9.17%	25.55B
ALNYLAM PHARMACEUTICALS, INC.	-20.42%	19.27B
BIO-TECHNE CORPORATION	+0.17%	12.15B
MEDPACE HOLDINGS, INC.	+28.07%	12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.24%	11.99B

Other Biotechnology & Medical Research

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW